- Home
- CWAN vs CORT Comparison
CWAN vs CORT Comparison
Compare CWAN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWAN
- CORT
- Stock Information
- Founded
- CWAN 2004
- CORT 1998
- Country
- CWAN United States
- CORT United States
- Employees
- CWAN N/A
- CORT N/A
- Industry
- CWAN Computer Software: Prepackaged Software
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- CWAN Technology
- CORT Health Care
- Exchange
- CWAN Nasdaq
- CORT Nasdaq
- Market Cap
- CWAN 7.3B
- CORT 7.1B
- IPO Year
- CWAN 2021
- CORT N/A
- Fundamental
- Price
- CWAN $22.03
- CORT $78.69
- Analyst Decision
- CWAN Buy
- CORT Strong Buy
- Analyst Count
- CWAN 9
- CORT 4
- Target Price
- CWAN $32.44
- CORT $142.00
- AVG Volume (30 Days)
- CWAN 3.4M
- CORT 1.1M
- Earning Date
- CWAN 04-30-2025
- CORT 05-05-2025
- Dividend Yield
- CWAN N/A
- CORT N/A
- EPS Growth
- CWAN N/A
- CORT 8.36
- EPS
- CWAN 1.71
- CORT 1.14
- Revenue
- CWAN $475,948,000.00
- CORT $685,446,000.00
- Revenue This Year
- CWAN $63.48
- CORT $35.85
- Revenue Next Year
- CWAN $29.35
- CORT $35.22
- P/E Ratio
- CWAN $12.87
- CORT $68.97
- Revenue Growth
- CWAN 23.21
- CORT 30.93
- 52 Week Low
- CWAN $17.63
- CORT $27.30
- 52 Week High
- CWAN $35.71
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- CWAN 35.01
- CORT 62.98
- Support Level
- CWAN $23.59
- CORT $74.34
- Resistance Level
- CWAN $23.89
- CORT $75.50
- Average True Range (ATR)
- CWAN 0.56
- CORT 3.21
- MACD
- CWAN -0.07
- CORT 0.50
- Stochastic Oscillator
- CWAN 3.71
- CORT 92.19
About CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.